SUMMIT, N.J.--(BUSINESS WIRE)--Nov. 13, 2009--
Celgene Corporation (NASDAQ: CELG) today announced its
presentation at the Lazard Capital Markets 6th Annual
Healthcare Conference on Tuesday, November 17, 2009 at 1:40 p.m. ET will
be webcast live and will be available in the investor relations section
of the company’s Web site at www.celgene.com.
Celgene management will provide an overview of the company.
Celgene Corporation, headquartered in Summit, New Jersey, is an
integrated global biopharmaceutical company engaged primarily in the
discovery, development and commercialization of novel therapies for the
treatment of cancer and inflammatory diseases through gene and protein
regulation. For more information, please visit the company’s Web site at www.celgene.com.
This release contains certain forward-looking statements which
involve known and unknown risks, delays, uncertainties and other factors
not under the Company's control, which may cause actual results,
performance or achievements of the Company to be materially different
from the results, performance or other expectations implied by these
forward-looking statements. These factors include results of current or
pending research and development activities, actions by the FDA and
other regulatory authorities, and those factors detailed in the
Company's filings with the Securities and Exchange Commission such as
10K, 10Q and 8K reports.
Source: Celgene Corporation
Celgene Corporation
David W. Gryska, 908-673-9059
Senior Vice
President and Chief Financial Officer
or
Brian P. Gill,
908-673-9530
Vice President, Corporate Communications
View printer-friendly version